• Thu
  • Apr 17, 2014
  • Updated: 12:04pm

Botulism milk powder scandal

On August 3, 2013, the world's biggest diary exporter Fonterra said a bacteria, Clostridium botulinum, which can cause botulism and affects muscles, had contaminated 40 tonnes of its whey protein, most of which was sold to manufacturers to make their own products, including milk powder. A day later, China banned all milk powder imports from New Zealand. Hong Kong recalled 80,000 cans of Cow & Gate baby formula. Other companies that were affected include Shanghai Yanjiu; Dumex Baby Food, a Danone brand; Wahaha Health Food and Wahaha Import & Export; Coca-Cola (China) and Abbott.

BusinessCommodities

NZ’s Fonterra cuts milk product prices in China amid probe

PUBLISHED : Thursday, 18 July, 2013, 8:49am
UPDATED : Tuesday, 06 August, 2013, 12:40pm

New Zealand’s Fonterra - the world’s largest dairy producer - will cut the price of one of it milk formula products in China, joining a growing list of firms responding to Beijing’s investigation into the sector.

Auckland-based Fonterra said it will reduce prices by up to 9 per cent for its Anmum brand of maternal milk products from Aug. 1. The move comes as the company prepares to enter China’s booming branded infant milk formula market later this year.

A number of international milk powder producers have cut prices in China after the country’s top economic planning agency said earlier this month it was investigating possible price-fixing and anti-competitive behaviour.

Fonterra’s managing director for China and India, Kelvin Wickham, said in a statement the move was aimed “to better meet consumer needs in light of recent industry-wide price revisions”.

Abbott Laboratories, French food giant Danone, Nestle, Mead Johnson Nutrition and Hong Kong-listed Biostime International Holdings have already announced reductions of up to 20 per cent on milk formula prices in China.

Drug pricing in China has also come under severe scrutiny, with China’s top regulators targeting British drugmaker GlaxoSmithKline, and announcing a crackdown on pricing in the wider pharmaceutical market.

China is a major export market for Fonterra. As well as its Anmum products, which are aimed at expectant mothers, it supplies the vast majority of milk powder imported by local producers for use in products ranging from Chinese branded milk formula to confectionary.

Fonterra said earlier this month that Beijing’s review of foreign milk formula brands had not affected its plan to launch its own branded infant milk formula in the country this year. The New Zealand firm is playing catch-up with other global dairy groups already operating in the high-margin Chinese market.

Dairy economists said the price cuts would shrink the fat margins seen on foreign-branded formula products in China, where tins costing less than us0 to produce can be sold for upwards of us0.

But the reduction was unlikely to push down global milk powder prices much, given growing demand for dairy products, particularly from emerging Asian countries.

“Formula producers have seen very healthy margins over the past few years and some of that is going to come out,” said Con Williams, rural economist at ANZ in Wellington.

“How much that flows into weaker demand for wholesale products such as skim milk or whole milk powder, I don’t think it will be substantial.”

The announced price cuts have done little to slow a rise in international prices for whole and skim milk powder, the dominant ingredients in infant milk formula.

At the latest global dairy auction held earlier this week by Fonterra, prices for whole milk powder rose 7.7 per cent, while skim milk powder prices rose 3.3 per cent.

Whole milk powder prices have surged 65 per cent so far this year, reflecting growing demand for processed dairy products, while skim milk powder prices are up 38 per cent.

Demand for international milk powder spiked in China after parents turned away from local products in 2008 when infant formula tainted with the industrial compound melamine killed at least six babies and made thousands sick with kidney stones.

Fonterra had held a stake in Chinese dairy company Sanlu, which collapsed after it was discovered to have used the compound in its products.

Share

Login

SCMP.com Account

or